Binh Dinh Pharmaceutical and Medical Equipment Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Binh Dinh Pharmaceutical and Medical Equipment.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 17.7% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 29 Mar 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 1,844,000 | N/A | N/A | 297,000 | 1 |
| 12/31/2023 | 1,651,770 | 231,387 | 160,298 | 293,991 | N/A |
| 9/30/2023 | 1,688,916 | 235,825 | 97,824 | 225,045 | N/A |
| 6/30/2023 | 1,654,996 | 238,441 | 32,683 | 142,021 | N/A |
| 3/31/2023 | 1,577,853 | 226,700 | 44,624 | 116,926 | N/A |
| 12/31/2022 | 1,554,821 | 209,457 | 82,184 | 165,012 | N/A |
| 9/30/2022 | 1,494,595 | 181,011 | 138,141 | 226,051 | N/A |
| 6/30/2022 | 1,654,406 | 168,156 | 50,499 | 126,854 | N/A |
| 3/31/2022 | 1,628,301 | 175,687 | 66,423 | 145,556 | N/A |
| 12/31/2021 | 1,558,504 | 162,646 | 62,932 | 117,568 | N/A |
| 9/30/2021 | 1,500,950 | 144,547 | 96,778 | 133,723 | N/A |
| 6/30/2021 | 1,224,917 | 151,994 | 221,693 | 256,933 | N/A |
| 3/31/2021 | 1,165,758 | 136,014 | 214,423 | 261,492 | N/A |
| 12/31/2020 | 1,256,952 | 138,916 | 153,173 | 212,908 | N/A |
| 9/30/2020 | 1,310,512 | 152,680 | 61,177 | 145,361 | N/A |
| 6/30/2020 | 1,341,568 | 136,409 | -82,716 | 49,943 | N/A |
| 3/31/2020 | 1,389,839 | 134,560 | -135,292 | 15,401 | N/A |
| 12/31/2019 | 1,261,729 | 128,005 | -150,664 | -1,036 | N/A |
| 9/30/2019 | 1,251,065 | 124,796 | -80,692 | 64,892 | N/A |
| 6/30/2019 | 1,309,152 | 137,586 | -28,596 | 63,220 | N/A |
| 3/31/2019 | 1,304,700 | 140,059 | 40,962 | 104,011 | N/A |
| 12/31/2018 | 1,401,024 | 146,704 | 63,781 | 107,861 | N/A |
| 9/30/2018 | 1,400,268 | 155,163 | 144,548 | 200,583 | N/A |
| 6/30/2018 | 1,382,479 | 153,894 | 164,758 | 220,783 | N/A |
| 3/31/2018 | 1,393,974 | 147,133 | 44,467 | 95,247 | N/A |
| 12/31/2017 | 1,388,227 | 147,952 | -32,010 | 17,716 | N/A |
| 9/30/2017 | 1,383,637 | 144,064 | N/A | 49,414 | N/A |
| 6/30/2017 | 1,383,273 | 132,605 | N/A | -24,637 | N/A |
| 3/31/2017 | 1,380,066 | 136,230 | N/A | 22,866 | N/A |
| 12/31/2016 | 1,384,902 | 125,049 | N/A | 114,486 | N/A |
| 9/30/2016 | 1,351,117 | 95,443 | N/A | -16,678 | N/A |
| 6/30/2016 | 1,312,923 | 102,804 | N/A | 75,945 | N/A |
| 3/31/2016 | 1,297,638 | 102,753 | N/A | 296,635 | N/A |
| 12/31/2015 | 1,225,068 | 188,618 | N/A | 261,854 | N/A |
| 12/31/2014 | 1,370,460 | 48,840 | N/A | 335,369 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if DBD's forecast earnings growth is above the savings rate (3.2%).
Earnings vs Market: Insufficient data to determine if DBD's earnings are forecast to grow faster than the VN market
High Growth Earnings: Insufficient data to determine if DBD's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if DBD's revenue is forecast to grow faster than the VN market.
High Growth Revenue: Insufficient data to determine if DBD's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DBD's Return on Equity is forecast to be high in 3 years time